Kanuma (Sebelipase Alfa Vials) 2mg/ml

Kanuma (sebelipase alfa) is an enzyme replacement therapy used to treat lysosomal acid lipase deficiency. This rare genetic condition affects the body's ability to break down fats. Kanuma helps manage symptoms by replacing the missing enzyme. Order Kanuma online for convenient delivery.

Strength

2mg/ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Alexion Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kanuma (sebelipase alfa) is prescribed to treat lysosomal acid lipase deficiency, a rare metabolic disorder that causes fat buildup in tissues and organs. It is used in both infants and adults to address symptoms like liver enlargement, poor growth, and high cholesterol. People often ask, 'What is sebelipase alfa used for?' to understand its role in managing this condition.

Side Effects

Kanuma works by providing the missing enzyme your body needs to break down fats properly. Patients may notice improved energy levels and reduced symptoms over time. Some users report better appetite and growth patterns after starting treatment. Effects vary by individual and condition severity.

Precautions & Warnings

Kanuma should be stored at ambient temperature and protected from light. Always check the vial for particles or discoloration before use. Do not use if the solution is cloudy or contains particles. Keep out of reach of children and pets. Consult your healthcare provider for proper handling and disposal.

Avoid Interactions

Limited information is available on drug interactions with Kanuma. However, it is generally advised to avoid alcohol and other medications that may affect liver function. Always inform your doctor about all medications, supplements, and herbal products you are taking. No specific interactions have been widely reported.

Frequently Asked Questions

Kanuma is used to treat lysosomal acid lipase deficiency, a rare genetic disorder affecting fat metabolism.

Kanuma is given as an intravenous infusion by a healthcare professional. The dose and frequency depend on the patient's condition.

No, Kanuma must be administered by a healthcare provider in a clinical setting due to its specialized nature.

Common side effects may include fever, vomiting, and diarrhea. Always consult your doctor if side effects persist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.